Clinical trials for Lagundi as COVID-19 cure, awaits FDA approval

Clinical trials for Lagundi as COVID-19 cure, awaits FDA approval




Is Lagundi the answer?
The country has always been known for its diverse flora and fauna, and its been ages that have relied to plants as the primary medicine long long before western medicine was accepted.

In this line, the University of the Philippines-Philippine General Hospital clinical trials on lagundi as treatment for the novel coronavirus 2019 disease are about to start after the UP_PGH ethics committee issued clearance for tests, DOST Sec. Fortunato dela Peña said.
Lagundi
(photo credit to owner)

Department of Science and Technology (DOST) projects for the COVID-19 national response,Secretary dela Peña reveals that the UP-PGH research and development team undertaking the clinical trials is just awaiting clearance from the Food and Drug Administration (FDA) before commencing.
DOST will be shouldering all the expenses for the Lagundi clinical trials.
“We approved a budget of P4.9 million,” Dela Peña told The STAR.

Currently, melatonin, convalescent plasma and virgin coconut oil (VCO) are undergoing study as a cure for COVID-19.
DOST will also fund for the research of tawa-tawa as potential cures for this infectious disease.




What can you say about this?
Share us your thoughts by simply leaving on the comment section below. For more news updates, feel free to visit our site often.
Stay updated with today's relevant news and trends by hitting the LIKE button.


Thanks for dropping by and reading this post.


Report from PhilStar


Disclaimer: Contributed articles does not reflect the view of THE PH CHRONICLES. This website cannot guarantee the legitimacy of some of the information contributed to us. You may do additional research if you find some information doubtfulNo part of this article maybe reproduced without permission from this website.

Post a comment

0 Comments